Galectin Therapeutics Reports 2024 Financial Results and Provides Business Update

Go back to Galectin Therapeutics Reports 2024 Financial Results and Provides Business Update
GALECTIN (NASDAQ: GALT) Delayed: 3.90 --0 (-0%)
Previous Close $3.90    52 Week High $3.05 
Open $3.90    52 Week Low $0.49 
Day High $3.90    P/E N/A 
Day Low $3.90    EPS $-1.32 
Volume 13